GSK vs SLRX · P/E 13, $103.31B cap vs $4.9M cap
GlaxoSmithKline PLC ADR (GSK) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the GSK and SLRX stock pages for the full models.
Not investment advice.